
Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries
The Pulse News website reported that major Korean biotech companies have turned to open innovation with overseas partners for faster access to innovative methods and global markets. On July 13, JW Pharmaceutical signed an R&D partnership with ARCH Venture Partners in yet another unprecedented approach to open innovation following its joint research
Comments Off on Korean Biotech Companies Pursue Open Innovation with Overseas Partners for Drug Discoveries • Read this story »
More Articles

Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value
The Korea Biomedical Review reported that Korean pharmaceutical and biotech companies are using various open innovation tools to raise competitiveness in new drug development in the global market. In the past, Korean drugmakers conducted research in secrecy due to the risk of technology leakage. But
Comments Off on Korean Biopharma Beefs Up Open Innovation to Raise Pipelines’ Value • Read this story »